Skip to main content

Table 3 Distribution of ER per study, categorized into 7 intervals. Given are percentages per interval. See Fig. A2 for more details

From: Investigating treatment-effect modification by a continuous covariate in IPD meta-analysis: an approach using fractional polynomials

 

ER (fmol/l)

 

0

1–5

6–10

11–20

21–100

101–1000

> 1000

Size

IBCSG-3

17.1

10.5

5.9

8.6

30.9

27.0

0.0

152

IBCSG-7

6.4

9.3

7.8

8.8

24.0

42.4

1.4

592

IBCSG-9

3.9

13.9

8.6

10.4

25.4

36.8

1.1

1177

NCIC-MA4

0.7

1.8

2.5

7.4

35.6

51.6

0.6

731

NSABP-B16–1

8.9

4.9

6.7

9.8

31.7

37.5

0.5

224

NSABP-B16–2

10.4

4.5

3.7

8.4

35.8

36.8

0.5

1071

NSABP-B20

0.1

0.0

1.0

12.4

42.9

42.6

1.0

966

SWOG-S8814

0.1

2.8

3.2

8.7

35.4

49.3

0.5

814

Total

4.3

5.7

4.6

9.5

33.3

41.8

0.8

5727